Time for government action on unreasonable drug price hikes
Many readers would have read about the outrageous price hike of the drug Daraprim (pyrimethamine) in the United States, which was acquired in August 2015 by Turing Pharmaceuticals. The price was then promptly raised to US$750 a tablet from US$13.50, bringing the annual cost of treatment for som…